CN105795468A - Composition having efficacy of losing weight - Google Patents
Composition having efficacy of losing weight Download PDFInfo
- Publication number
- CN105795468A CN105795468A CN201610147875.3A CN201610147875A CN105795468A CN 105795468 A CN105795468 A CN 105795468A CN 201610147875 A CN201610147875 A CN 201610147875A CN 105795468 A CN105795468 A CN 105795468A
- Authority
- CN
- China
- Prior art keywords
- fat
- parts
- weight
- effect
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000000694 effects Effects 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 23
- 241000219357 Cactaceae Species 0.000 claims abstract description 18
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 18
- 229940094952 green tea extract Drugs 0.000 claims abstract description 18
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 18
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 14
- 230000001603 reducing effect Effects 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- 210000000582 semen Anatomy 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 9
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 229920001202 Inulin Polymers 0.000 claims description 3
- 229920001100 Polydextrose Polymers 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 3
- 229940029339 inulin Drugs 0.000 claims description 3
- 239000001259 polydextrose Substances 0.000 claims description 3
- 235000013856 polydextrose Nutrition 0.000 claims description 3
- 229940035035 polydextrose Drugs 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 abstract description 8
- 235000019698 starch Nutrition 0.000 abstract description 8
- 239000008107 starch Substances 0.000 abstract description 8
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 238000010521 absorption reaction Methods 0.000 abstract description 5
- 230000000968 intestinal effect Effects 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 238000007493 shaping process Methods 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 33
- 241000700159 Rattus Species 0.000 description 21
- 238000012360 testing method Methods 0.000 description 16
- 230000037396 body weight Effects 0.000 description 13
- 208000008589 Obesity Diseases 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 12
- 206010033307 Overweight Diseases 0.000 description 10
- 235000020824 obesity Nutrition 0.000 description 10
- 210000000577 adipose tissue Anatomy 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 235000013305 food Nutrition 0.000 description 7
- 238000003304 gavage Methods 0.000 description 6
- 238000011835 investigation Methods 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 5
- 229960001243 orlistat Drugs 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000021590 normal diet Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000004132 lipogenesis Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108700022737 rat Fat1 Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000282894 Sus scrofa domesticus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003392 amylase inhibitor Substances 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004783 oxidative metabolism Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides a composition having an efficacy of losing weight. The composition consists of phaseolus vulgaris fruit extract, soluble dietary fibers, green tea extract, cactus powder and L-carnitine. The composition consists of the following raw materials in parts by weight: 1-50 parts of phaseolus vulgaris fruit extract, 10-90 parts of water-soluble dietary fibers, 1-10 parts of green tea extract, 1-20 parts of cactus powder and 1-10 parts of L-carnitine. The components of the composition have synergistic effects, so that the composition can effectively block starch degradation, inhibit starch absorption, inhibit fat synthesis, promote fat metabolism and conversion, fully block fat production, regulate intestinal flora, reach the effects of losing weight, shaping body, and controlling weight in a regular consumption, and at the same time is also suitable for patients with diabetes to take.
Description
Technical field
The present invention relates to a kind of efficacy, a kind of compositions with effect of weight reducing.
Background technology
In recent years, socioeconomic developing rapidly, material is more and more abundanter, daily life level
Being improved, living and diet structure is also along with there occurs change.Simultaneously as the public is to health knowledge
Shortage, overweight and fat be increasingly becoming affect the healthy important public hygiene problem of people's life it
One.Within 2006, in the 10th world's obesity conference that Sydney, AUS is held, participant expert send sternly
Strict warning: obesity is a social problem, constitutes a threat to female mental；Obesity is that a medical science is asked equally
Topic, may will shorten the life-span of following several generations；And it or a whole world have to faced by serious
Economic problems.It is the chronic disease of maximum that whole world adult faces that World Health Organization (WHO) (WHO) explicitly points out obesity
Disease, regards fat as one of big medical science social problem of the world four.
At present in developed country, overweight and obese people occupies the biggest ratio, and cause because of fat is strong
Kang Wenti the most increasingly causes the concern of people.According to the statistics of 1998, there are about the crowd of 25% in the U.S.
Being in fat state, in annual dead crowd, about 280000～325000 cause due to obesity,
Causing can being positioned at second, be only second to smoking in Precaution factors of death；And it is strong according to U.S.'s third time
Health nutrition education generaI investigation data show, in the adult of more than 20 years old, there are about 50.4% be in overweight with
Fat state.The situation of Britain also allows of no optimist, it is estimated that, to the year two thousand twenty, men and women's obese people will divide
Do not account for the 34% and 38% of total population.The problem of obesity of old people also merits attention, U.S.'s tune of 2000
Look into display, 65-74 year elderly population in, the male of 33% and the women of 39% are in fat state.
Since reform and opening-up, China's income of residents has had bigger growth, meanwhile, the traditional food of China
Culture and the social mode of Chinese style, the rapid growth for obese people is laid a good foundation.According to 2005
Portion show for the investigation of 209849 example samples, China resident is overweight and the ratio of obese people respectively
It is 17.6% and 5.6%, adds up to and account for the 23.2% of total investigation population；This part of investigation also shows significantly
Urban-rural Difference, Urban population is overweight and fat ratio is higher than rural population, the most metropolitan overweight and fertile
Fat rate is respectively 25.0%, 10.6%.The situation in domestic each province and city is not quite similar: within 2010, Kunming is to 5381
The investigation of example crowd shows, overweight and obese people accounts for 25.73% and 8.09% respectively, the most also shows
Women is higher than the phenomenon of male；One investigation display of Tianjin, this area is overweight and obesity rates is up to 51.2%.
From these numerically it can be seen that the ratio of the overweight/obesity crowd of China mutually with developed country
Under.And along with the adjustment of Industry Structure and the support of national policy, traditional backward areas, as
The economy in west area, rural area will be developed faster, according to conventional experience, incident general
It can be the outburst of Overweight-obesity crowd.
Fat unfavorable to the health of human body.Numerous disease has been found out in relevant research, such as type Ⅱdiabetes mellitus,
Cardiovascular diseases, osteoarthritis, hypertension, immune function depression etc. are all relevant with obesity, thus cause
Metabolic syndrome becomes the second largest cause of the death after smoking.Along with body weight increases, people are not only made to suffer from
Sick probability rises, and corresponding medical expense is also increasing, and all can to the physiology of people, psychological aspects
Bring adverse influence.
Along with the increase of fat number, the concern of obese people is the most gradually heated up by society.Improve fat shape
Condition, is not only a Man's Demands, the especially main trend of society.So, diet products contain huge
The market demand, has lasting captivation to the obese people day by day pursuing healthy living.
Summary of the invention
The technical problem to be solved is to provide a kind of compositions with effect of weight reducing.
For solving above-mentioned technical problem, the technical scheme is that
A kind of compositions with effect of weight reducing, by Semen Phaseoli Vulgaris extract, water soluble dietary fiber, green tea
Extract, cactus powder and L-carnitine composition, the part of Semen Phaseoli Vulgaris extract 1-50 based on its parts by weight,
Water soluble dietary fiber 10-90 part, green tea extract 1-10 part, cactus powder 1-20 part, left-handed meat
Alkali 1-10 part.
Preferably, the above-mentioned compositions with effect of weight reducing, Semen Phaseoli Vulgaris extract based on its parts by weight
10-40 part, water soluble dietary fiber 50-80 part, green tea extract 4-9 part, cactus powder 3-10 part,
L-carnitine 2-7 part.
Preferably, the above-mentioned compositions with effect of weight reducing, Semen Phaseoli Vulgaris extract 35 based on its parts by weight
Part, water soluble dietary fiber 70 parts, green tea extract 8 parts, cactus powder 5 parts, L-carnitine 5 parts.
Preferably, the above-mentioned compositions with effect of weight reducing, described Semen Phaseoli Vulgaris extract passes through extraction process by water
Prepare.
Preferably, the above-mentioned compositions with effect of weight reducing, described water soluble dietary fiber be resistant dextrin,
Inulin, the one of polydextrose or combination in any.
Preferably, the above-mentioned compositions with effect of weight reducing, described green tea extract passes through extraction process by water system
?.
Preferably, the above-mentioned compositions with effect of weight reducing, described cactus powder by Radix et Caulis Opuntiae Dillenii and/or
Radix et Caulis Opuntiae Dillenii fruit carries out extraction process by water and prepares.
The preparation method of the above-mentioned compositions with effect of weight reducing, specifically comprises the following steps that
By Semen Phaseoli Vulgaris extract, water soluble dietary fiber, green tea extract, cactus powder, L-carnitine
Cross 80-100 mesh sieve, mixer mixes 30-60 minute, after having mixed, carries out fill.
The usage and dosage of the above-mentioned compositions with effect of weight reducing: 20g/ days, take at twice.
The invention has the beneficial effects as follows:
The above-mentioned compositions with effect of weight reducing, each component synergism, effectively block amylolysis, press down
Starch processed absorbs, and suppression lipogenesis, promotion lipid metabolism and conversion, comprehensive obstruction fat produce,
Regulating intestinal canal flora, often eats, and can reach to lose weight, mould build, the effect of control body weight,
Meanwhile, said composition also is adapted for diabetes patient and takes.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme of the present invention is further described.
A kind of compositions with effect of weight reducing, by Semen Phaseoli Vulgaris extract, water soluble dietary fiber, green tea
Extract, cactus powder and L-carnitine composition, (Semen Phaseoli Vulgaris extract, aqueous soluble dietary are fine for each component
Dimension, green tea extract, cactus powder and L-carnitine) it is commercial goods, Semen Phaseoli Vulgaris extract passes through
Extraction process by water obtains, and green tea extract is obtained by extraction process by water, and cactus powder is obtained by extraction process by water,
Described water soluble dietary fiber is that resistant dextrin, inulin and polydextrose are by weight 1:1:1 mixing group
Close.Concrete consumption is shown in Table 1.
Table 1
The preparation method of the described compositions with effect of weight reducing, specifically comprises the following steps that
By Semen Phaseoli Vulgaris extract, water soluble dietary fiber, green tea extract, cactus powder, L-carnitine
Cross 80 mesh sieves, mixer mixes 45 minutes, after having mixed, carries out fill.
The above-mentioned compositions with effect of weight reducing, in each component:
Semen Phaseoli Vulgaris extract has warming the middle warmer and descending qi, profit the intestines and stomach, the only function such as singultus, kidney tonifying complement, is one
Plant nourishing dietetic therapy good merchantable brand.Semen Phaseoli Vulgaris extract is rich in alpha-amylase inhibitor and dietary fiber.Alphalise starch
Enzyme inhibitor is a kind of pure-natural biological active substance, belongs to the one of glycosylhydrolase inhibitor, and it passes through
Effectively block or delay high starch food (rice, wheaten food, miscellaneous grain crops and relevant snacks and cake) forms sediment
The hydrolysis of powder and digestion, reduce the decomposition of starchy carbohydrate material in food and absorb, for obese patient, and can
Minimizing sugar, to adipose conversion, delays intestinal to empty, and increase fat consumption is to alleviate weight, thus plays
Fat-reducing effect.
Green tea extract main component tea polyphenols, is Catechin in Tea class, flavonoid, phenolic acids and flower
The general name of pigment compound, its mechanism of action may have three below aspect: 1. strengthens muscular tissue fat
The oxidative metabolism rate of fat acid；2. the synthesis of body fat tissue is reduced；3. intestinal satisfied fatty acid is suppressed
Absorb.Have aid digestion and drop low-fat important effect.
Water soluble dietary fiber is relatively more effective for reducing cholesterol, in the metabolism in the way of fermentation of big enteral,
The energy provided is less than common carbohydrate；In food, form full-bodied colloidal sol and gel, easily produce
Raw satiety；With the material such as protein, fat formed complex, reduce human body to starch, protein and
The absorption of fat；Promote the fat consumption of internal storage.During loss of weight, assist sending out of overall efficacy
Wave.
Among the people in China, Radix et Caulis Opuntiae Dillenii and Radix et Caulis Opuntiae Dillenii fruit be used for curing mainly heart peratodynia disease, cough, have sore throat,
Acute mastitis, furuncle, parotitis etc., also can make nourishing and fit keeping function health care and be used.The triterpene soap contained in cactus powder
Glycoside can regulate human secretory function and the activity of regulation lipase, promotes that superabundant fats decomposes, and energy
Effectively stop fat in intestinal absorption.One random, comparison, in double-blind trial, 49 regulars
The women of weight (between 20 and 25) participates in test, and result shows that the group on time taking Radix et Caulis Opuntiae Dillenii fruit powder does not has
There is notable fat mass to change, and placebo group has substantially weightening finish (at most 3 kilograms increases).Cactus powder
Can reach diuresis and control body weight effect, Radix et Caulis Opuntiae Dillenii fruit powder not on blood and the impact of mineral,
For good dietary supplement or functional food or Weight management beverage.
L-carnitine can improve the aerobatic exercise rush fat metabolism to fat and super severe one, effectively
Increase the fall heavily fat reducing effect of aerobatic exercise.
Above-mentioned each component influences each other, synergism, for blocking the source that fat produces, adipose conversion
Process is designed, and does not affect normal diet, formula collocation rationally, can at normal diet, disappear
While hunger sensation, effectively block the decomposition of starch in high starch food, block 80% calorie intake,
Do not affect the absorption of other nutritional labeling, and do not enter blood circulation, do not act on cerebral nerve
Maincenter, fat-reducing the most not appetite-suppressing, do not have diarrhoea, weak, anorexia phenomenon, body weight does not rebounds,
Glucose absorption can also be reduced simultaneously, thus reduce insulin secretion, reduce lipogenesis, be suitable for sugar
Urine sick obese patient take；Can reduce abdominal part and subcutaneous fat, blood fat, blood glucose and the gallbladder in blood is solid
Alcohol, helps fat-reducing, forms precipitation with cholesterol, thus also inhibits the absorption of intestinal inner cholesterol, promotees
Enter the beta-oxidation of fatty acid, thus promote that lipid metabolism is changed into energy；Effectively reduce cholesterol, produce
Keep digestive system healthy while satiety, reduce the harmful intestinal tract bacteria causeed fat.
Efficacy experiments:
1 material and instrument
1.1 laboratory animals and feedstuff
SPF level SD rat 72, male, weight about 100 ± 10g, by Beijing, dimension tonneau China is real
Test zoo technical company limited to provide, feeding environment temperature 18-22 DEG C, natural lighting, freely ingest and drink
Water.
High lipid food: 80% normal feedstuff, 10% yolk powder and 10% Adeps Sus domestica.
1.2 laboratory animal environment:
SPF level barrier environment, the quality certification number: SYXK (Tianjin) 2012-0004.
1.3 medicines and reagent
There is the compositions of effect of weight reducing: be configured to concentration with distilled water during use and divide described in embodiment 1-9
Do not set basic, normal, high dosage group with 5 times, 10 times and 30 times of human body recommended dose (20g/ days).
Orlistat (or listat, orlistat): Basel, SUI Hao Fumai Roche company limited produces；
It is configured to the gavage liquid that concentration is 10mg/mL, by 60mg kg with distilled water-1·d-1Gastric infusion.
1.4 main apparatus and consumables associated therewiths
Gastric perfusion needle, syringe, balance, refrigerated centrifuger, dissecting instrument, spectrophotometer (Siemens
Dimension RxL Max full automatic biochemical apparatus), cholesterol, sodium cholate, serum total cholesterol (TC),
Triglyceride (TG), HDL-C (HDL) measure test kit.
2 experimental techniques
By rat adaptability feed 7d under experimental situation, it is randomly divided into 6 groups: blank group；Model
Matched group；Positive drug control group and Weight reducing compound are divided into basic, normal, high dosage group, and often group 12 is big
Mus.Timing every day gavage, feeding (feedstuff administered dose is respectively organized equal).Blank group gavage distilled water,
Feed normal diet (is pulled together purchased from Austria of section)；Model control group gavage distilled water, feed height fat nutrient fodder；
Positive controls is with orlistat solution gavage；Weight reducing compound basic, normal, high dosage group distilled water reconstitutes
Liquid gavage.Test 40 days.Record during experiment every treated animal to appetite, surplus appetite and berley amount, fixed
Phase weighs, it is long to survey body, and fasting 12h at the end of experiment, femoral artery takes blood, isolates serum to be measured.Solve
Cut open rat, perusal rat body fat calmness situation and internal organs situation of change.Take body fat (testis and
Perirenal fat pad) and weigh.
3 data process and result judges
Experiment SPSS16.0 carries out statistical analysis.
4 interpretations of result
The impact on obese rat body weight of 4.1 Weight reducing compounds
Before weight-reducing experiment starts, each group rat body weight there was no significant difference (P > 0.05), after testing 40 days,
Fat-reducing matched group and experiment contrast group are close to blank group body weight, and pole is substantially less than obese model group rat
Body weight.Compare with model control group, blank group, fat-reducing matched group and basic, normal, high dosage three
Rats in test groups body weight is all significantly lower than model control group (P < 0.05), and basic, normal, high dosage three
Test group and blank group and fat-reducing matched group compare and there was no significant difference (P > 0.05), the results are shown in Table 2.
The impact on obese rat body weight of table 2 Weight reducing compound
Note: compare with model control group, * is P < 0.05.
The impact on obese rat body fat weight of 4.2 Weight reducing compounds
Blank group, fat-reducing matched group and 3 rats in test groups kidneys, surrounding genital fat after 40 days
Weight all significantly lower than model control group (P < 0.05), and three test group of basic, normal, high dosage with
Blank group and fat-reducing matched group compare and there was no significant difference (P > 0.05).Between each test group and with
Blank group, fat-reducing matched group there was no significant difference (P > 0.05) more statistically.The results are shown in Table
3。
The impact on obese rat body fat weight of table 3 Weight reducing compound
Note: compare with model control group, * is P < 0.05.
The impact on obese rat Lee ' s index of 4.3 Weight reducing compounds
Lee's index is similar with Body Mass Index BMI of people, main reflection body obese degree.
After 40 days, Lee ' the s index of blank group, fat-reducing matched group and rats in test groups is all significantly lower than
Model control group (P < 0.05), and between three test group of basic, normal, high dosage and test group is with empty
Difference there are no significant meaning (P > 0.05) between white matched group and fat-reducing matched group.The results are shown in Table 4.
The impact on obese rat Lee ' s index of table 4 Weight reducing compound
Note: compare with model control group, * is P < 0.05.
The impact on obese rat fat coefficient of 4.4 Weight reducing compounds
Fat coefficient=body fat weight/body weight × 100%
Fat coefficient is the percentage ratio of kidney and surrounding genital fat pad and rat body weight in rat body, also
Reflect rat body fat number with the obese degree of rat.
After 40 days, the fat coefficient of blank group, fat-reducing matched group and rats in test groups is all significantly lower than mould
Type matched group (P < 0.05), and between three test group of basic, normal, high dosage and test group is with blank
Difference there are no significant meaning (P > 0.05) between matched group and fat-reducing matched group, the results are shown in Table 5.
The impact on obese rat fat coefficient of table 5 Weight reducing compound
Conclusion:
Obesity is most commonly that this experiment is built due to the Simple Obesity that Energy intaking is too much caused at present
Vertical obese rat model, similar to mankind's Feeding regularity, there is important reality meaning for fat research
Justice.
Orlistat is the conventional slimming medicine that U.S. food Drug Administration (FDA) ratifies up to now
One of.This experiment selects orlistat as fat-reducing positive control drug, facilitates look at subtracting of Weight reducing compound
Fertilizer efficiency fruit.
This experimentation shows, compositions of the present invention is to experimental rat body weight, the reduction effect of body fat
Substantially, there is notable effect of weight reducing.In three dosage, the action effect of high dose group is best.
Above-mentioned retouch in detail what the compositions with effect of weight reducing of the present invention was carried out with reference to embodiment
State, be illustrative rather than determinate, can according to restriction scope list several embodiments,
Therefore changing and modifications under without departing from present general inventive concept, within should belonging to protection scope of the present invention.
Claims (7)
1. a compositions with effect of weight reducing, it is characterised in that: by Semen Phaseoli Vulgaris extract, water solublity
Dietary fiber, green tea extract, cactus powder and L-carnitine composition, Semen Phaseoli Vulgaris based on its parts by weight
Extract 1-50 part, water soluble dietary fiber 10-90 part, green tea extract 1-10 part, cactus powder
1-20 part, L-carnitine 1-10 part.
The compositions with effect of weight reducing the most according to claim 1, it is characterised in that: heavy by it
Amount number meter Semen Phaseoli Vulgaris extract 10-40 part, water soluble dietary fiber 50-80 part, green tea extract 4-9
Part, cactus powder 3-10 part, L-carnitine 2-7 part.
The compositions with effect of weight reducing the most according to claim 2, it is characterised in that: heavy by it
Amount number meter Semen Phaseoli Vulgaris extract 35 parts, water soluble dietary fiber 70 parts, green tea extract 8 parts, celestial being
People slaps 5 parts of powder, L-carnitine 5 parts.
4. according to the compositions with effect of weight reducing one of claim 1-3 Suo Shu, it is characterised in that:
Described Semen Phaseoli Vulgaris extract is prepared by extraction process by water.
5. according to the compositions with effect of weight reducing one of claim 1-3 Suo Shu, it is characterised in that:
Described water soluble dietary fiber is resistant dextrin, inulin, the one of polydextrose or combination in any.
6. according to the compositions with effect of weight reducing one of claim 1-3 Suo Shu, it is characterised in that:
Described green tea extract is prepared by extraction process by water.
7. according to the compositions with effect of weight reducing one of claim 1-3 Suo Shu, it is characterised in that:
Described cactus powder is prepared by extraction process by water.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610013692 | 2016-01-08 | ||
| CN2016100136922 | 2016-01-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105795468A true CN105795468A (en) | 2016-07-27 |
Family
ID=56467431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610147875.3A Pending CN105795468A (en) | 2016-01-08 | 2016-03-15 | Composition having efficacy of losing weight |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105795468A (en) |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106962733A (en) * | 2017-04-12 | 2017-07-21 | 广东盛元中天生物科技有限公司 | A kind of solid beverage for helping fat-reducing |
| CN107006744A (en) * | 2017-03-16 | 2017-08-04 | 河北以岭医药研究院有限公司 | A kind of navy bean solid beverage and its preparation technology |
| CN107114787A (en) * | 2017-05-09 | 2017-09-01 | 宝健（北京）生物技术有限公司 | A kind of composition of prevention heat absorption |
| CN107259567A (en) * | 2017-08-08 | 2017-10-20 | 合肥康桥工贸有限公司 | A kind of starch of high thermal stability absorbs blocking agent |
| CN107912770A (en) * | 2017-10-09 | 2018-04-17 | 无比滴（广东）药业有限公司 | A kind of oral blocking agent for effectively suppressing food starch taken in excess |
| CN108095113A (en) * | 2017-12-22 | 2018-06-01 | 成都博创必成医药技术有限公司 | A kind of composition, preparation and its application with fat reducing blood sugar reducing function |
| CN109222101A (en) * | 2018-11-29 | 2019-01-18 | 汤臣倍健股份有限公司 | Composition and health food with effect of weight reducing |
| CN109259240A (en) * | 2018-10-12 | 2019-01-25 | 人和未来生物科技（长沙）有限公司 | Adjust composition and its application of intestinal flora and prevention and treatment obesity |
| CN110973527A (en) * | 2019-11-15 | 2020-04-10 | 济南仙诗丽健康科技有限公司 | Health weight-losing agent |
| CN111387376A (en) * | 2020-03-05 | 2020-07-10 | 江苏微康生物科技有限公司 | Probiotic herbal beverage with effects of moistening intestines and discharging oil and preparation method thereof |
| CN112369577A (en) * | 2020-10-27 | 2021-02-19 | 东莞自然衡健康科技有限公司 | Sugar-resistant beauty composition and preparation method thereof |
| CN112568430A (en) * | 2020-02-29 | 2021-03-30 | 河北康平健康产业有限责任公司 | A composition comprising semen Phaseoli vulgaris and fructus Momordicae Charantiae for reducing weight and fat, and its preparation method |
| CN112741320A (en) * | 2021-01-11 | 2021-05-04 | 杭州佰倍优生物科技有限公司 | Weight-losing composition and preparation method and application thereof |
| CN112971154A (en) * | 2021-04-08 | 2021-06-18 | 吉林省强参生物技术有限公司 | Solid mixture rich in water-soluble dietary fibers and alpha-amylase inhibitor, and preparation method and application thereof |
| CN113826799A (en) * | 2021-09-26 | 2021-12-24 | 山东森健生物科技发展有限公司 | Diet food |
| CN114403403A (en) * | 2021-12-29 | 2022-04-29 | 北京思维晶格科技有限公司 | Jelly with fat reducing and weight losing effects and preparation method thereof |
| CN116870127A (en) * | 2023-07-20 | 2023-10-13 | 延边大学 | Compound garlic skin composition and preparation method and application thereof |
| CN118044624A (en) * | 2024-03-21 | 2024-05-17 | 广东三荷生物科技有限公司 | Composition containing dietary fiber and preparation method thereof |
| CN118235864A (en) * | 2024-05-29 | 2024-06-25 | 北京逯博士行为医学科技研究院有限公司 | Weight-losing composition for improving metabolic efficiency and strengthening spleen and tonifying kidney and preparation method thereof |
-
2016
- 2016-03-15 CN CN201610147875.3A patent/CN105795468A/en active Pending
Cited By (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107006744A (en) * | 2017-03-16 | 2017-08-04 | 河北以岭医药研究院有限公司 | A kind of navy bean solid beverage and its preparation technology |
| CN106962733A (en) * | 2017-04-12 | 2017-07-21 | 广东盛元中天生物科技有限公司 | A kind of solid beverage for helping fat-reducing |
| CN107114787B (en) * | 2017-05-09 | 2020-11-13 | 宝健（北京）生物技术有限公司 | Composition for preventing heat absorption |
| CN107114787A (en) * | 2017-05-09 | 2017-09-01 | 宝健（北京）生物技术有限公司 | A kind of composition of prevention heat absorption |
| CN107259567A (en) * | 2017-08-08 | 2017-10-20 | 合肥康桥工贸有限公司 | A kind of starch of high thermal stability absorbs blocking agent |
| CN107912770A (en) * | 2017-10-09 | 2018-04-17 | 无比滴（广东）药业有限公司 | A kind of oral blocking agent for effectively suppressing food starch taken in excess |
| CN108095113A (en) * | 2017-12-22 | 2018-06-01 | 成都博创必成医药技术有限公司 | A kind of composition, preparation and its application with fat reducing blood sugar reducing function |
| CN109259240A (en) * | 2018-10-12 | 2019-01-25 | 人和未来生物科技（长沙）有限公司 | Adjust composition and its application of intestinal flora and prevention and treatment obesity |
| CN109222101A (en) * | 2018-11-29 | 2019-01-18 | 汤臣倍健股份有限公司 | Composition and health food with effect of weight reducing |
| CN110973527A (en) * | 2019-11-15 | 2020-04-10 | 济南仙诗丽健康科技有限公司 | Health weight-losing agent |
| CN112568430A (en) * | 2020-02-29 | 2021-03-30 | 河北康平健康产业有限责任公司 | A composition comprising semen Phaseoli vulgaris and fructus Momordicae Charantiae for reducing weight and fat, and its preparation method |
| CN111387376A (en) * | 2020-03-05 | 2020-07-10 | 江苏微康生物科技有限公司 | Probiotic herbal beverage with effects of moistening intestines and discharging oil and preparation method thereof |
| CN112369577A (en) * | 2020-10-27 | 2021-02-19 | 东莞自然衡健康科技有限公司 | Sugar-resistant beauty composition and preparation method thereof |
| CN112741320A (en) * | 2021-01-11 | 2021-05-04 | 杭州佰倍优生物科技有限公司 | Weight-losing composition and preparation method and application thereof |
| CN112971154A (en) * | 2021-04-08 | 2021-06-18 | 吉林省强参生物技术有限公司 | Solid mixture rich in water-soluble dietary fibers and alpha-amylase inhibitor, and preparation method and application thereof |
| CN113826799A (en) * | 2021-09-26 | 2021-12-24 | 山东森健生物科技发展有限公司 | Diet food |
| CN114403403A (en) * | 2021-12-29 | 2022-04-29 | 北京思维晶格科技有限公司 | Jelly with fat reducing and weight losing effects and preparation method thereof |
| CN114403403B (en) * | 2021-12-29 | 2024-01-12 | 未名太研生物科技(绍兴)有限公司 | Jelly with fat and weight reducing effects and preparation method thereof |
| CN116870127A (en) * | 2023-07-20 | 2023-10-13 | 延边大学 | Compound garlic skin composition and preparation method and application thereof |
| CN116870127B (en) * | 2023-07-20 | 2024-09-06 | 延边大学 | Compound garlic skin composition and preparation method and application thereof |
| CN118044624A (en) * | 2024-03-21 | 2024-05-17 | 广东三荷生物科技有限公司 | Composition containing dietary fiber and preparation method thereof |
| CN118235864A (en) * | 2024-05-29 | 2024-06-25 | 北京逯博士行为医学科技研究院有限公司 | Weight-losing composition for improving metabolic efficiency and strengthening spleen and tonifying kidney and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105795468A (en) | Composition having efficacy of losing weight | |
| CN102919836B (en) | Health-care product capable of reducing blood glucose, releasing pressure, reducing lipid, relaxing bowel, beautifying, losing weight and resisting fatigue and production process thereof | |
| CN102907604B (en) | Health-care product having effects of reducing blood sugar and pressure, losing weight, relaxing bowels, maintaining beauty and resisting fatigue and production process thereof | |
| CN104322617B (en) | Biscuit of a kind of auxiliary hyperglycemic and preparation method thereof | |
| CN102366093A (en) | Composite slimming health food | |
| CN101253903B (en) | Health food with fat-reducing function and its preparation | |
| CN1830318A (en) | Dietary fiber food | |
| CN101579120A (en) | Nutritional food with weight-losing function and preparation method thereof | |
| CN103169090A (en) | Synthetic rice suitable for patients with diabetes mellitus and preparation method thereof | |
| CN105707707A (en) | Super quinoa nutrition powder for pregnant and lying-in women | |
| CN108771239A (en) | A kind of strengthening the spleen and stomach herbal paste and preparation method thereof | |
| CN103285145A (en) | Pure traditional Chinese medicine preparation for prompting rapid growth of pigs as well as preparation method and application method thereof | |
| CN106070985A (en) | A kind of eucommia Bark male flower pressed candy and production technology thereof | |
| CN102204649A (en) | Healthcare food for regulating and stabilizing blood sugar and method for preparing same | |
| CN102551046A (en) | Natural health composition for weight reduction and application of same | |
| CN105943958A (en) | Inonotus obliquus composite solid particles for treating gout and preparing method thereof | |
| CN105707378A (en) | Black-highland barley coffee with effect of slimming | |
| CN109170916A (en) | One kind keeps fit and healthy food compositions and preparation method thereof | |
| CN105707681A (en) | Supermicro black fungus nutrient porridge with blood sugar reducing function and making method thereof | |
| CN103920140B (en) | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation | |
| CN103238757A (en) | Compound feed containing fermented cottonseed meal for chicken for eggs and preparation method thereof | |
| CN109549032A (en) | A kind of light body function beverage and preparation method thereof of losing weight | |
| CN102150779B (en) | Health food for regulating and stabilizing blood sugar and preparation method thereof | |
| CN108450941A (en) | A kind of dietary composition adjusting lipid metaboli | |
| CN103181557A (en) | Nutritious food with slimming function and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160727 |